Scholarlink

Background <p>Legislative reform in Ireland and Europe, including the introduction of a Health Information Bill in Ireland and the European Health Data Space (EHDS) Regulation, promote strong governance of health data, including control over how health data is used for different purposes, such as individual care, research, planning and policy-making. The aim of this study was to explore key stakeholders’ perspectives on the role of patients in enabling inclusive and ethical use of health data for primary and secondary purposes in Ireland.</p> Methods <p>This was a cross-sectional qualitative study with focus group design. Thirty-five participants were evenly distributed across five groups: Academics and Researchers; Data Controllers, Data Protection Officers and Ethics Experts; Patients and Public; Healthcare Professionals and the Industry Group. A semi-structured approach guided by a topic guide was used, and thematic data analysis was conducted.</p> Results <p>This study identified strong support for increased patient involvement. However, contradictions in participants’ views within and across groups were found particularly around patient control over health data and data ownership and embedding Patient and Public Involvement (PPI) in research. Most of the participants agreed that patient autonomy over health data is of ‘vital’ importance; yet they advocated for staged and delayed patient access. Similarly, the participants believed that PPI was required to drive the direction of research and funding allocation; however, patients’ lack of understanding of research areas was a challenge. Concerns were expressed around informed consent required for sharing of patient data, particularly with the industry, and around the timing of consent when patients are at their most vulnerable.</p> Conclusion <p>Participants expressed strong support for increased patient involvement in the use of health data in Ireland; however, there were contrasting views in relation to data control and ownership, consent processes and PPI. These findings have implications for policy development in the implementation of the EHDS in Europe, and the establishment of the Health Data Access Body in Ireland. This study emphasises the importance of patient involvement to support successful implementation of new health information systems and data access infrastructure.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

If it wasn’t for us, there would be no data: stakeholders’ perspectives on patient involvement in the use of health data in Ireland

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月28日

查看全文
  • Tina Bedenik,
  • Fiona Geaney,
  • Barbara Foley,
  • Rachel Flynn,
  • Kathleen E. Bennett

摘要

Background

Legislative reform in Ireland and Europe, including the introduction of a Health Information Bill in Ireland and the European Health Data Space (EHDS) Regulation, promote strong governance of health data, including control over how health data is used for different purposes, such as individual care, research, planning and policy-making. The aim of this study was to explore key stakeholders’ perspectives on the role of patients in enabling inclusive and ethical use of health data for primary and secondary purposes in Ireland.

Methods

This was a cross-sectional qualitative study with focus group design. Thirty-five participants were evenly distributed across five groups: Academics and Researchers; Data Controllers, Data Protection Officers and Ethics Experts; Patients and Public; Healthcare Professionals and the Industry Group. A semi-structured approach guided by a topic guide was used, and thematic data analysis was conducted.

Results

This study identified strong support for increased patient involvement. However, contradictions in participants’ views within and across groups were found particularly around patient control over health data and data ownership and embedding Patient and Public Involvement (PPI) in research. Most of the participants agreed that patient autonomy over health data is of ‘vital’ importance; yet they advocated for staged and delayed patient access. Similarly, the participants believed that PPI was required to drive the direction of research and funding allocation; however, patients’ lack of understanding of research areas was a challenge. Concerns were expressed around informed consent required for sharing of patient data, particularly with the industry, and around the timing of consent when patients are at their most vulnerable.

Conclusion

Participants expressed strong support for increased patient involvement in the use of health data in Ireland; however, there were contrasting views in relation to data control and ownership, consent processes and PPI. These findings have implications for policy development in the implementation of the EHDS in Europe, and the establishment of the Health Data Access Body in Ireland. This study emphasises the importance of patient involvement to support successful implementation of new health information systems and data access infrastructure.